Safeguard Scientifics, Inc. (NYSE:SFE), a holding company that builds value in growth-stage life sciences and technology companies, announced that it will release its financial results for the fourth quarter and year ended December 31, 2011 prior to market open on Wednesday, February 29, 2012. Please call at least 10 minutes prior to the call to register. Wednesday, February 29, 2012 at 9:00am EST.
Safeguard Scientifics, Inc. is a private equity and venture capital firm specializing in expansion financings, growth capital, management buyouts, recapitalizations, industry consolidations, corporate spinouts, growth stage, and early stage financings.
**********************************
PEPCO Holdings Inc. (NYSE:POM) has scheduled an earnings conference call for February 24, 2012, at 11 a.m. EST. Fourth-quarter 2011 earnings will be released before the market opens on Friday, February 24, 2012. Investors, members of the media, and other interested persons may access the conference call on the Internet at http://www.pepcoholdings.com/investors or by calling 1-866-713-8395 before 10:55 a.m. The pass code for the call is 28200193. International callers may access the call by dialing 1-617-597-5309,using the same pass code, 28200193. An on-demand replay will be available for seven days following the call. To hear the replay, dial 1-888-286-8010 and enter pass code 39586558. International callers may access the replay by dialing 1-617-801-6888 and entering the same pass code, 39586558. An audio archive will be available at PHI’s website.
Pepco Holdings, Inc., through its subsidiaries, engages in the transmission, distribution, and supply of electricity.
**********************************
Allergan, Inc. (NYSE:AGN) announced operating results for the quarter ended December 31, 2011. Allergan also announced that its Board of Directors has declared a fourth quarter dividend of $0.05 per share, payable on March 16, 2012 to stockholders of record on February 24, 2012. Allergan reported $0.90 diluted earnings per share attributable to stockholders compared to $0.85 diluted earnings per share attributable to stockholders for the fourth quarter of 2010.
Allergan, Inc. operates as a multi-specialty healthcare company primarily in the United States, Europe, Latin America, and the Asia Pacific.
CRWESelect, a stock highlight publication is pleased to alert investors of stocks on the move.
Sign Up for our Free Stock Newsletter at http://www.crweselect.com/signup
*******************
THIS IS NOT A RECOMMENDATION TO BUY OR SELL ANY SECURITY!
Disclaimer: Never invest in any stock featured on our site or emails unless you can afford to lose your entire investment. CRWESelect.com publisher and its affiliates and contractors are not registered investment advisers or broker/dealers.Our disclaimer( http://crweselect.com/disclaimer) is to be read and fully understood before using our site, reading our newsletter or joining our email list. Release of Liability: Through use of this website viewing or using, you agree to hold CRWESelect.com report and Crown Equity Holdings Inc. CRWE, its operators, shareholders, employees and/or contractors harmless and to completely release them from any and all liability due to any and all loss (monetary or otherwise), damages (monetary or otherwise) that you may occur. Rule 17B requires disclosure of payment for investor relations. Crown Equity Holdings Inc. (CRWE.OB) is a media-advertisement and newswire company. Crown Equity Holdings Inc. (CRWE.OB), in some cases, provides media advertising and public awareness for both public and private companies, as well as disseminating news. As such, in some cases, when Crown Equity Holdings Inc. (CRWE.OB) advertises for a particular client, Crown Equity Holdings Inc. (CRWE.OB) charges an advertising fee which it must disclose under 17B. The fee may be in cash, in free trading stock or in restricted stock. Crown Equity Holdings Inc. (CRWE.OB), if paid in stock, can and may sell those securities during the advertising period.
